Literature DB >> 29788069

Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.

Petra Weimers1, Jonas Halfvarson2, Michael C Sachs3, Rachel Saunders-Pullman4, Jonas F Ludvigsson5,6, Inga Peter7, Johan Burisch1, Ola Olén8,9,10.   

Abstract

Background: Few studies have examined the association between inflammatory bowel disease (IBD) and Parkinson's disease (PD).
Methods: To estimate the incidence and relative risk of PD development in a cohort of adult IBD, we included all incident IBD patients (n = 39,652) in the Swedish National Patient Register (NPR) between 2002 and 2014 (ulcerative colitis [UC]: n = 24,422; Crohn's disease [CD]: n = 11,418; IBD-unclassified [IBD-U]: n = 3812). Each IBD patient was matched for sex, age, year, and place of residence with up to 10 reference individuals (n = 396,520). In a cohort design, all incident PD occurring after the index date was included from the NPR. In a case-control design, all incident PD occurring before the index date was included. The association between IBD and PD and vice versa was investigated by multivariable Cox and logistic regression.
Results: In IBD, there were 103 cases of incident PD, resulting in hazard ratios (HRs) for PD of 1.3 (95% confidence interval [CI], 1.0-1.7; P = 0.04) in UC, 1.1 (95% CI, 0.7-1.7) in CD, and 1.7 (95% CI, 0.8-3.0) in IBD-U. However, these effects disappeared when adjusting for number of medical visits during follow-up to minimize potential surveillance bias. In a case-control analysis, IBD patients were more likely to have prevalent PD at the time of IBD diagnosis than matched controls, with odds ratios of 1.4 (95% CI, 1.2-1.8) in all IBD patients, 1.4 (95% CI, 1.1-1.9) for UC, and 1.6 (95% CI, 1.1-2.3) for CD patients alone. Conclusions: IBD is associated with an increased risk of PD, but some of this association might be explained by surveillance bias. 10.1093/ibd/izy190_video1izy190.video15785623138001.

Entities:  

Mesh:

Year:  2019        PMID: 29788069     DOI: 10.1093/ibd/izy190

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  43 in total

Review 1.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

Review 2.  The gut microbiota-brain axis in behaviour and brain disorders.

Authors:  Livia H Morais; Henry L Schreiber; Sarkis K Mazmanian
Journal:  Nat Rev Microbiol       Date:  2020-10-22       Impact factor: 60.633

Review 3.  Is Parkinson's disease a chronic low-grade inflammatory bowel disease?

Authors:  Malvyne Rolli-Derkinderen; Laurène Leclair-Visonneau; Arnaud Bourreille; Emmanuel Coron; Michel Neunlist; Pascal Derkinderen
Journal:  J Neurol       Date:  2019-04-12       Impact factor: 4.849

Review 4.  Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Authors:  Paulina Gonzalez-Latapi; Connie Marras
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 5.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 6.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

Review 7.  Initiation and Transmission of α-Synuclein Pathology in Parkinson's Disease.

Authors:  Alex Mazurskyy; Jason Howitt
Journal:  Neurochem Res       Date:  2019-11-11       Impact factor: 3.996

Review 8.  The Microbiome as a Modifier of Neurodegenerative Disease Risk.

Authors:  P Fang; S A Kazmi; K G Jameson; E Y Hsiao
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

9.  Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study.

Authors:  Tuomas H Mertsalmi; Anna But; Eero Pekkonen; Filip Scheperjans
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study.

Authors:  Mun Kyung Sunwoo; Yong Wook Kim; Seo Yeon Yoon; Jaeyong Shin; Seok-Jae Heo; Jee Suk Chang
Journal:  J Neurol       Date:  2021-07-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.